Current affiliation: Department of Radiation Oncology, CHA Bundang Medical Center, CHA University, Seongnam, Korea
Hypoxia can impair the therapeutic efficacy of radiotherapy (RT). Therefore, a new strategy is necessary for enhancing the response to RT. In this study, we investigated whether the combination of nanoparticles and RT is effective in eliminating the radioresistance of hypoxic tumors.
Gold nanoparticles (GNPs) consisting of a silica core with a gold shell were used. CT26 colon cancer mouse model was developed to study whether the combination of RT and GNPs reduced hypoxia-induced radioresistance. Hypoxia inducible factor-1α (HIF-1α) was used as a hypoxia marker. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining were conducted to evaluate cell death.
Hypoxic tumor cells had an impaired response to RT. GNPs combined with RT enhanced anti-tumor effect in hypoxic tumor compared with RT alone. The combination of GNPs and RT decreased tumor cell viability compare to RT alone
In the present study, hypoxic tumors treated with GNPs + RT showed favorable responses, which might be attributable to the ROS production induced by GNPs + RT. Taken together, GNPs combined with RT seems to be potential modality for enhancing the response to RT in hypoxic tumors.
New technologies in radiotherapy (RT) have been developed to overcome the low tolerance of normal tissue and achieve a high therapeutic ratio. For example, image-guided RT has been used to identify the exact tumor location and the relationship between the tumor and normal organs. Intensity-modulated RT was developed to deliver high doses of radiation precisely to the tumor location by using a stiff dose gradient. Despite the use of these technologically advanced methods, tumor responses are limited in cases of hypoxic tumors. Hypoxia is a key regulatory factor in tumor growth [
One of measures to overcome the limitations of RT is the use of nanoparticles in RT. Nanoparticles are utilized for various purposes in antitumor treatments, such as drug delivery [
We hypothesized that increased ROS production due to GNPs combined with RT overcomes the limited effect of RT under hypoxic conditions. This study was aimed at investigating the enhancement of RT efficacy using GNPs and evaluating the potential for increasing RT efficacy under hypoxic conditions.
HIF-1α antibody was purchased from Abcam (Cambridge, UK), and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was obtained from Sigma (St. Louis, MO, USA).
The GNPs used in this study consisted of a silica core with a gold shell. Silica nanoparticles (SNPs) were functionalized with 3-aminopropyl triethoxysilane to help attachment of gold seeds (1–2 nm). Gold seeds were deposited onto the SNPs. Further gold coverage of the SNPs was accomplished by the reduction of gold hydroxide by hydroxylamine hydrochloride on the SNP surface (
Mouse CT26 colon cancer cells were used for all experiments. The cells were cultured in RPMI 1640 (Gibco, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (FBS) and 1% antibiotics and maintained at 37°C in a 5% CO2 incubator. They were subcultured every 3–4 days to maintain exponential growth.
Mouse CT26 colon cancer cells (4 × 103 cells/well) were plated onto 96-well plates. After 24 hours, the cells were incubated with 2 μg/mL GNP for 24 hours at 37°C in a 5% CO2 incubator. After incubation, the cells were washed with phosphate buffered saline (PBS) to remove excess GNPs. The effect of GNPs on cell viability was evaluated using the MTT assay at 24 hours after GNP exposure.
For
To investigate the synergistic effect of GNPs and RT on cell growth inhibition under hypoxic conditions in comparison with that of RT alone, 4 × 103 cells/well were incubated with 2 μg/mL GNP for 24 hours at 37°C in a 0.1% O2, 5% CO2, and balanced N2, respectively. After incubation, the cells were washed with PBS to remove excess GNPs followed by 8 Gy irradiation. A single fraction of 8 Gy was delivered to the tumor cells by using a X-RAD 320 irradiator (Precision X-Ray, North Branford, CT, USA) and cell viability was evaluated using the MTT assay.
The TUNEL assay was performed according to the manufacturer’s instructions (Promega Co., Madison, WI, USA). Briefly, after deparaffinization and rehydration, tissue sections were incubated with proteinase K (20 μg/mL) for 15 minutes at 24°C and washed in PBS. The slides were incubated with a mixture of TdT enzyme and biotinylated nucleotide for 60 minutes at 37°C. After being washed in PBS, the slides were incubated with streptavidin-horseradish peroxidase (HRP) solution for 30 minutes at 24°C. To detect TUNEL-positive signals, the slides were incubated with a mixture of 3,3’-diaminobenzidine (DAB) substrate, chromogen, and hydrogen peroxide. The slides were then examined and the images were recorded using a microscope (Olympus BX53F; Olympus, Tokyo, Japan). Dark brown staining represented a positive reaction. Positive reactions showed under the microscope, and stained cells were quantified by stereological analysis using Image-J software (
CT26 cells were cultured in a 6-well plate for 24 hours followed by 6 Gy irradiation. After incubation for 2 hours, the cells were treated with a fluorogenic probe, as an indicator, for ROS detection and measurements were performed using a fluorescence microscope (Zeiss, Jena, Germany). Dichlorodihydrofluorescein, supplied as a diacetate ester (DCFH DA), is readily oxidized to the highly fluorescent dichlorofluorescein (DCF) after enzymatic or base-catalyzed cleavage of the diacetate groups; 10 mM N-acetyl-L-cysteine (NAC) was used as a ROS scavenger.
The CT26 mouse colon cancer model was developed to investigate the synergistic effect of GNP in combination with RT on tumor growth. We injected 106 CT26 mouse colon cancer cells into the thigh of BALB/c mice subcutaneously. When tumor diameter reached 6 mm or 12 mm, GNPs (100 μg Au) were injected into tumors; thereafter, the tumors were irradiated with 10 Gy in a single fraction by using X-RAD 320 irradiator (Precision X-Ray). The mice were placed at a distance of 69 cm from the radiation source and treated at a dose rate of 150 cGy/min with 300 kVp X-rays, using 12.5 mA and a X-ray beam filter consisting of 2.0 mm Al. Tumor volume was calculated using the formula 0.5 × ab2, where a is the long axis and b is the short axis of two orthogonal diameters. The mice were divided into the following 4 groups (A, control; B, GNPs; C, RT; D, GNPs + RT). Tumor growth delay was observed for 18 days.
Twenty four hours after irradiation, mice were sacrificed. Tumors were fixed in 4% paraformaldehyde and embedded in paraffin. The blocks were cut into 5-μm-thick sections. Antigen retrieval was accomplished at 37°C with protease K solution. For immunofluorescence staining, deparaffinized sections were blocked with 10% normal horse serum for 1 hour and then incubated with primary antibodies against HIF-1α for overnight at 4°C (Abcam). After washing with PBS, the samples were incubated for 1 hour with a PE conjugated secondary antibody (Thermo Fisher Scientific, Waltham, MA, USA). Reactions showed under the fluorescence microscope, and HIF-1α stained cells were quantified using Image-J software.
Tumor cell growth was compared using the Student t-test, and tumor growth was compared using repeated-measures ANOVA. A p-value less than 0.05 was considered statistically significant. All statistical analyses were performed using SPSS ver. 20.0 (IBM, Armonk, NY, USA).
The GNPs were imaged using transmission electron microscopy (
To investigate synergistic effect of GNPs used in combination with RT on TGI, CT26 cells were treated with GNPs in the absence or presence of radiation. After administration of 2, 8 Gy in a single fraction to CT26 tumor cells, a dose-response relationship was observed at various concentrations of GNPs (
GNPs combined with RT increased apoptosis significantly (
To evaluate the effect of hypoxia on TGI, tumors with different diameters after treatment with 10 Gy in a single fraction were compared (
To evaluate the synergistic effect of GNPs in combination with RT under hypoxic conditions, tumor volumes of the mice in the 4 groups (A, B, C, and D) were compared (
To investigate the mechanism of the synergistic effect of GNPs combined with RT, cell viability was compared using the MTT assay (
ROS generation was observed using a fluorogenic probe (
Oxygen is well-established radiosensitizer. Free radicals generated after irradiation break the DNA double strand and induce biological damage in tumors. Oxygen fixes DNA damage, resulting in enhancement of RT efficacy [
Tumor cells often are under hypoxic conditions. In particular, in large tumors, some tumor cells are located far from blood vessels. Tumor blood vessels are immature, and therefore, temporary obstruction occurs often. Hypoxic conditions affects both the DNA damage repair pathway and cell survival signaling pathway [
We observed that hypoxic tumor cells had an impaired response to RT. GNPs combined with RT enhanced the antitumor effect in hypoxic tumor cells. After irradiation, the survival of hypoxic tumor cells was higher than that of normoxic tumor cells. Addition of GNPs decreased tumor cell viability significantly. The tumor growth was impaired in both small tumor and large tumors after administration of 10 Gy in a single fraction. However, large tumors, which had more hypoxic tumor cells, showed a poor response. When we evaluated tumor growth after the administration of 10 Gy in a single fraction, the tumors treated with GNPs + RT showed a higher response than that shown by the tumors treated with RT alone. With regard to tumor cell death, the cells treated with GNPs + RT and NAC showed a higher survival rate than that shown by the cells that were not treated with NAC. Apoptosis due to ROS was one of the main mechanisms of cell death.
In clinical practice, stereotactic body radiotherapy (SBRT) is used to overcome the radioresistance of hypoxic tumors [
Some studies pointed out the discrepancy between predicted dose enhancement via a photoelectric effect and the radiobiological response of GNPs combined with RT [
GNPs in combination with RT induce decreased clonogenic cell survival, increased apoptosis, and DNA damage [
GNPs combined with RT may have boost effect to tumor area. Berbeco et al. [
This study was insufficient to gather robust evidence for the enhancement of RT efficacy by GNPs to overcome hypoxia. GNPs were administered by intratumoral injection, and we could not be sure that they were distributed evenly in the tumor. The absorbed dose was not measurable. It could be odd that tumors with 12 mm diameter were defined as hypoxic tumors based on HIF-1α immunohistochemistry staining. Tumors in different size may have different characteristics. Furthermore, hypoxia is not the only factor that can influence on radiation sensitivity. In future studies, we should follow a way to make hypoxic tumor with similar size as a previous work [
Finally, in this study, GNPs combined with RT exhibited a favorable response in hypoxic tumors, which were resistant to RT. RT administered with high-tech therapeutic machinery alone has not shown a favorable effect in hypoxic tumors and tolerability in normal tissues, simultaneously. However, GNPs combined with RT enhanced ROS generation in hypoxic tumors, leading to tumor cell apoptosis. Thus, GNPs combined with RT may have potential for enhance the efficacy of RT. We expect further studies on clinical application of GNPs combined with RT.
This work was supported by the Korean Society for Radiation Oncology (KOSRO) Young Investigator Fund.
Gold nanoparticle (GNP) characterization. (A) Schematic illustration of the synthesis of GNPs. (B) Transmission electron micrograph of gold shell formation in SNP-GNPs (SNP-GNS) with different amounts of gold hydroxide solution: (a) 5 mL, (b) 10 mL, and (c) 20 mL. (C) Color changes from SNP-GNP to SNP-GNS. (D) Absorption spectra of SNP-GNPs and SNP-GNS. (E) MTT viability assay of CT26 cells treated with increasing concentrations of GNPs for 24 hours. Cells were incubated with 2 μg/mL GNP for 24 hours and washed with new media to remove excess GNPs. Cell viability was evaluated using the MTT assay at 24 hours after GNP exposure. Error bars, viability (mean ± standard deviation of three replicates). All experiments were performed in triplicate. MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; APTES, 3-aminopropyltriethoxysilane; THPC, tetrakis (hydroxymethyl) phosphonium chloride.
Enhancement of radiosensitivity using gold nanoparticles. (A) MTT viability assay of CT26 cells after 2, 8 Gy irradiation at various concentration of gold nanoparticles (GNPs). CT26 cells were pre-treated with GNPs at various concentrations for 24 hours and irradiated after washing with new media. After 48 hours, cell viability was evaluated by MTT assay. (B) Apoptosis assay in CT26 cells treated with radiotherapy (RT) and GNPs + RT. CT26 cells were treated GNP with 2 μg/mL for 24 hours, followed by irradiation with 8 Gy after washing. Cells were stained with FITC-annexin V and propidium iodide for detection of apoptotic cells at 48 hours after irradiation. All experiments were performed in triplicate. MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide. *p < 0.05.
Effect of hypoxia on tumor growth inhibition. (A) Tumor volume after 10 Gy irradiation in a single fraction. (B) Immunohistochemical staining for hypoxia inducible factor-1α (HIF-1α) in tumors with different diameters. (C) Tumor volume in 4 groups of mice after treatment. (D) Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining of tumors in 4 groups of mice after treatment. All experiments were performed in triplicate. GNP, gold nanoparticle; RT, radiotherapy; DAPI, 4’,6-diamidino-2-phenylindole. *p < 0.05.
Reactive oxygen species (ROS) evaluation. (A) MTT viability assays of CT26 cells after treatment under normoxic and hypoxic conditions. Error bars, viability (mean ± standard deviation of six replicates). (B) Relative ROS generation in CT26 cells after treatment under normoxic and hypoxic conditions. All experiments were performed in triplicate. MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; GNP, gold nanoparticle; NAC, N-acetyl-L-cysteine; RT, radiotherapy. *p < 0.05.